DexCom, Inc. Profile Avatar - Palmy Investing

DexCom, Inc.

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, a…
Medical - Devices
US, San Diego [HQ]

Ratios

15 Sheets · Starting from 2023
Margins, Growth Rates In %
Ratio 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Profitability
Gross Margin
12.33 37.92 47.00 46.65 62.56 68.02 69.25 66.00 68.49 64.36 63.11 66.44 68.63 64.72 63.19
Profit Margin
-180.26 -113.45 -58.67 -54.55 -18.62 -8.64 -14.33 -11.44 -6.99 -12.32 6.85 25.62 6.32 11.73 14.95
Operating Margin
-154.36 -93.13 -58.80 -55.76 -18.06 -8.29 -14.20 -11.15 -5.92 -18.06 9.64 15.54 7.16 13.44 16.50
EPS Growth
36.17 20.00 29.17 -17.65 50.00 25.50 -141.61 -11.11 25.00 -140.00 177.78 367.86 -69.47 120.00 59.09
Return on Assets (ROA)
-114.01 -71.50 -37.14 -51.42 -24.33 -12.13 -19.73 -16.29 -5.55 -6.63 4.22 11.50 3.18 6.33 8.64
Return on Equity (ROE)
290.18 -90.45 -42.82 -70.78 -35.43 -15.98 -26.04 -23.11 -11.97 -19.16 11.45 27.02 6.87 16.01 26.18
Return on Invested Capital (ROIC)
-162.46 -86.80 -42.82 -64.76 -31.79 -14.91 -25.59 -25.69 -6.15 -11.11 6.81 17.92 3.83 8.10 9.77
Solvency
Equity Ratio
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Debt/Assets
99.38 0.68 - - 6.60 5.55 2.49 0.79 -8.04 32.54 53.34 47.84 42.87 37.46 38.68 41.41
Debt/Equity
-252.95 0.86 - - 9.09 8.09 3.28 1.04 -11.42 70.15 154.08 129.81 100.71 80.92 97.82 125.40
Debt/EBITDA
-99.13 12.68 6.21 2.25 166.21 312.56 146.76 137.85 318.16 122.06 425.23 267.02 277.29 346.15 221.20
Debt/Capitalization
165.38 0.85 - - 8.33 7.48 3.18 1.03 -12.89 41.23 60.64 56.49 50.18 44.73 49.45 55.63
Interest Debt per Share USD
0.31 0.01 - - 0.03 0.03 0.02 0.01 -0.09 0.89 2.96 3.31 5.10 4.97 5.40 6.77
Debt Growth
-26.36 -98.88 -100.00 - - -2.86 -32.35 -50.00 160.87 5,360.00 208.39 13.40 60.56 -0.96 14.47 24.39
Liquidity
Current Ratio
196.42 436.41 708.30 397.95 290.03 359.36 345.74 273.44 536.14 764.16 546.75 557.69 511.15 199.47 284.44
Quick Ratio
167.62 355.50 640.78 349.74 251.40 310.34 282.96 220.12 491.65 724.96 505.16 510.70 450.26 172.32 238.53
Cash Ratio
19.03 32.32 17.32 41.54 134.58 176.85 128.70 92.29 317.85 511.24 123.88 133.14 146.03 34.92 36.39
Operating Cash Flow Ratio
-200 -200 -200 -100 - - - - - - - - - - - - - - - - - - - - - -
Turnover
Inventory Turnover
985.69 372.14 494.70 720.27 665.56 518.13 351.14 429.30 500.89 520.09 454.51 275.50 214.95 334.76 238.28
Receivables Turnover
850.80 728.99 607.84 512.31 613.03 611.32 542.51 563.72 535.00 455.05 515.54 449.64 476.08 407.94 366.82
Payables Turnover
1,001.23 1,717.18 1,440.04 1,366.67 1,426.19 406.37 317.74 286.20 259.63 249.97 212.36 395.96 134.03 113.85 482.42
Asset Turnover
63.25 63.02 63.30 94.25 130.61 140.41 137.67 142.33 79.47 53.84 61.63 44.91 50.34 53.97 57.82
Coverage
Interest Coverage
-569.71 -2,925.71 -407,663.64 -27,850.00 -3,211.11 -2,687.50 -14,275.00 -9,128.57 -332.03 -820.70 235.99 353.60 171.96 2,103.23 2,944.33
Asset Coverage
- - 11,900 - - 1,100 1,300 3,100 9,700 4,300 200 100 100 100 200 200 100
Cash Flow Coverage (CFGR)
-84.42 -8,128.76 - - -472.86 35.29 513.04 2,130.43 -173.46 31.27 12.05 27.45 25.85 24.29 32.10 28.86
EBITDA Coverage
-500 -2,200 -373,500 -24,500 -2,400 -2,600 -14,200 -9,100 -200 -400 200 400 200 2,200 4,500
Dividend Coverage
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Time Interest Earned (TIE)
- - - - - - - - - - - - - - - - - - - - 100 100 100 100 100
Market Prospects
Dividend Yield
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Earnings Yield
-14.94 -7.11 -7.32 -5.83 -1.18 -0.54 -0.88 -1.31 -1.01 -1.20 0.51 1.41 0.30 0.77 1.13
Price/Earnings (P/E)
-669.46 -1,406.77 -1,366.36 -1,714.35 -8,446.11 -18,477.71 -11,349.33 -7,610.66 -9,867.77 -8,313.42 19,712.20 7,070.82 33,573.02 12,923.70 8,845.57
Price/Book (P/B)
-1,942.66 1,272.47 585.12 1,213.40 2,992.79 2,952.22 2,955.34 1,759.19 1,181.12 1,593.00 2,257.99 1,910.84 2,306.79 2,068.47 2,315.51
Price/Sales (P/S)
1,206.76 1,595.93 801.66 935.26 1,573.09 1,596.84 1,626.17 870.85 689.44 1,024.27 1,350.21 1,811.47 2,121.19 1,515.42 1,322.33
Price/Cash Flow (P/CF)
-909.71 -1,818.62 -2,029.45 -2,822.72 104,872.50 17,538.17 13,341.26 8,883.62 5,384.37 8,576.59 6,336.74 7,338.43 11,737.28 6,586.36 6,399.30
End of DXCM's Analysis
CIK: 1093557 CUSIP: 252131107 ISIN: US2521311074 LEI: - UEI: -
Secondary Listings
DXCM has no secondary listings inside our databases.